Finance

Lists
Why is NXTCL down ६.७५%?
Dive Deeper
NXTCL:STO
NextCell Pharma AB
SEK ०.२३
-६.७५%
(-०.०१६) 1D
नोभेम्बर १८, १७:२१:५४ GMT+१  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for NXTCL...
Open
SEK ०.२३
High
SEK ०.२५
Low
SEK ०.२२
Mkt. cap
२.९४ करोड
Avg. vol.
१०.०९ लाख
Volume
८८.८२ हजार
52-wk high
SEK १.७८
52-wk low
SEK ०.२०
EPS
-SEK ०.४५
Shares outstanding
११.१४ करोड
No. of employees
२१
Open
SEK ०.२३
High
SEK ०.२५
Low
SEK ०.२२
Mkt. cap
२.९४ करोड
Avg. vol.
१०.०९ लाख
Volume
८८.८२ हजार
52-wk high
SEK १.७८
52-wk low
SEK ०.२०
EPS
-SEK ०.४५
Shares outstanding
११.१४ करोड
No. of employees
२१
News stories
From web sources and news partners
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees२१
Founded२०१४ मार्च १९
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ मे
२०२५ अगस्ट
२०२६ मार्च
२०२६ जुन
Revenue
२२.६२ लाख
१८.२६ लाख
२७.८३ लाख
३०.३५ लाख
Cost of goods sold
२१.१३ लाख
१९.२८ लाख
१८.२० लाख
१९.०३ लाख
Cost of revenue
२१.१३ लाख
२२.०४ लाख
१८.२० लाख
१९.०३ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९६.८५ लाख
१.३२ करोड
१.०९ करोड
१.२२ करोड
Operating expense
१.०५ करोड
९१.१२ लाख
१.१४ करोड
१.२९ करोड
Total operating expenses
१.२६ करोड
१.५७ करोड
१.३२ करोड
१.४८ करोड
Operating income
-१.०४ करोड
-१.३९ करोड
-१.०५ करोड
-१.१७ करोड
Other non operating income
-
-१.००
-
-
EBT including unusual items
-१.०३ करोड
-१.३८ करोड
-१.०४ करोड
-१.१७ करोड
EBT excluding unusual items
-१.०३ करोड
-१.३८ करोड
-१.०४ करोड
-१.१७ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
२.०१ लाख
-१.२० लाख
-८१.३३ हजार
३७.३६ हजार
Net income
-१.०३ करोड
-१.३८ करोड
-१.०४ करोड
-१.१७ करोड
Net profit margin
-४५४.१५%
-३४२.२६%
-३७३.२५%
-३८४.७७%
Earnings per share
-
-
-
-
Interest and investment income
८२.२५ हजार
१.६२ लाख
७९.४७ हजार
५०.९६ हजार
Interest expense
-
-१.५९ हजार
-१.१९ हजार
-१८८.००
Net interest expenses
८२.२५ हजार
१.०९ लाख
७८.२८ हजार
५०.७८ हजार
Depreciation and amortization charges
६.१५ लाख
६.३८ लाख
६.२५ लाख
६.१७ लाख
EBITDA
-९७.३८ लाख
-१.३३ करोड
-९८.३९ लाख
-१.११ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू